• October 31, 2026



Choice Institutional Equities is bullish on Senores Pharma has recommended buy rating on the stock with a target price of Rs 1700 in its research report dated October 30, 2026.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

The real estate reset: resilience, refinancing and returns

Gold, silver prices on October 30: Check latest rates in Delhi, Mumbai, Kolkata, other cities

Related Posts

3 Dividend ETFs with 25% Upside Over the Next Year, According to Wall Street Analysts

By  

Trading, Fees, App & More Explained

By  

4 Simple Vanguard ETFs Worth Buying and Holding for the Next 20 Years

By  

NGX money market fund in 2025: What investors can expect in 2026

By